Department of Biomedical Engineering at UNIST is cultivating a culture of interdisciplinary
and innovative research. Various research centers and clusters are actively working together to
advance our mission of building a foundation for a better and healthy future.
Center for Human Data Science
Center for Human Data Science aims to deepen our understandings on human cognition and in turn, make human life better.
We use multidisciplinary approach that integrates methods from Cognitive Science, Psychology, Decision-making,
Biomechanics, and Computational Neuroscience. The broad goal of the Human Data Science center is to build a system
that generates high quality human data, and to develop its application that makes daily lives better. Moreover, we expect
our attempts would bridge the gaps between neurocognitive understandings of human information processes and
engineering studies in developing human-like artificial intelligence systems.
PI and co-PIs: Sung-Phil Kim, Dongil Chung, Youngshin Kwak, Oh-Sang Kwon, Dooyoung Jung, Gwanseop Shin
KOGIC is the UNIST and Ulsan City genome center established in 2017. Previously it was TGI (The Genomics Institute of UNIST).
KOGIC as a center has professors, postdocs, and students who are engaged in genomics and bioinformatics research both in
experimental and informatics fields. KOGIC carries out the Korean Genome Project jointly with Genome Research
Foundation of Korea
PI and co-PIs: Jong Hwa Park, Seung Woo Cho, Semin Lee
Global R&D Center for Organ Mimetics
Global R&D Center for Organ Mimetics (GROM) at UNIST aim to develop a high-throughput drug-screening platform based
on the organ-mimetic devices. We team up with two world-leading research groups in regenerative medicine and
translational research, Wake Forest Institute for Regenerative Medicine (WFIRM) and University of Basel based, respectively,
in the US and Switzerland. This trilateral international collaboration works to apply the science of pharmaceutical chemistry,
microfluidics, bioprinting, and related disciplines of regenerative medicine to achieve disruptive technological platform
for drug development.
PI and co-PIs: Joo H. Kang, Sung Chul Bae, Woonggyu Jung, Hyun-Wook Kang, Tae-Eun Park
Stem Cell Research Center (http://hsscrc-eng.unist.ac.kr/)
Hans Schöler Stem Cell Research Center (HSSCRC) at UNIST has a network with Max Planck Institute, Germany as a Max Planck
Partner Group (MPPG). HSSCRC aims to develop novel stem cell technologies to treat incurable diseases. HSSCRC is mainly
focused on the generation of patient-specific stem cells using direct conversion technology, which can directly generate
target cells by bypassing the pluripotent stage thereby solving the tumorigenic risk of pluripotent stem cells. Additionally,
HSSCRC focuses on developing stem cells-based tissue using organoid technology and 3D bio printing technology to
investigate new treatments to repair impaired tissues or organ damage in Regenerative Medicine.
PI and co-PIs: Jeong-Beom Kim, Hyun-Wook Kang
Center for Cell to Cell Communication in the Cancer (C5) Center
Because intracellular or intercellular signaling controls various physiological activities in the living organisms, the
malfunction of these signaling systems is directly linked with cancer and other diseases. There are many attempts to
identify molecular diagnostic and therapeutic targets by tracking abnormalities in these signal pathways inside cancer cells.
However, studies of the cell-cell communication between cancer cells and surrounding healthy cells have not been studied
sufficiently. The C5 center aims to present a new strategy to fight against cancer by understanding intercellular signaling
communication that involves controlling the growth of cancer cells and metastasis.
PI and co-PIs: Semin Lee, HyungJoon Cho, Taejoon Kwon